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Abstract
Background: Numerous reports have described the epidemiological and clinical characteristics of influenza A
(H1N1) 2009 infected patients. However, data on the effects of bacterial coinfection on these patients are very
scarce. Therefore, this study explores the impact of bacterial coinfection on the clinical and laboratory parameters
amongst H1N1 hospitalized patients.
Findings: This retrospective study involved hospitalized patients with laboratory-confirmed H1N1 infections
(September 2009 to May 2010). Relevant clinical data and the detection of bacterial coinfection from respiratory or
sterile site samples were obtained. Multiplex PCR was used to determine the co-existence of other respiratory
viruses. Comparison was made between patients with and without bacterial coinfection. The occurrence of
coinfection was 34%; 14 (28%) bacterial and only 3 (6%) viral. Mycoplasma pneumoniae (n = 5) was the commonest
bacteria followed by Staphylococcus aureus (n = 3). In univariate analysis, clinical factors associated with bacterial
coinfection were age > 50 years (p = 0.02), presence of comorbidity (p = 0.04), liver impairment (p = 0.02),
development of complications (p = 0.004) and supplemental oxygen requirement (p = 0.02). Leukocytosis (p =
0.02) and neutrophilia (p = 0.004) were higher in bacterial coinfected patients. Multivariate logistic regression
analysis revealed that age > 50 years and combined complications were predictive of bacterial coinfection.
Conclusions: Bacterial coinfection is not uncommon in H1N1 infected patients and is more frequently noted in
the older aged patients and is associated with higher rates of complications. Also, as adjunct to clinical findings,
clinicians need to have a higher index of suspicion if neutrophilia was identified at admission as it may denote
bacterial coinfection.
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Background
In April 2009, a novel influenza A (H1N1) virus
emerged in Mexico and spread rapidly worldwide [1].
By June 11, 2009 nearly 30, 000 cases had been con-
firmed across 74 countries including Malaysia, prompt-
ing World Health Organization to raise its pandemic
alert to phase 6 [2]. After the first reported H1N1 case
in Malaysia in May 15, 2009, the numbers increased
exponentially and as of May 31, 2010 they totaled 14,
821 with 87 deaths [3]. Thereafter, there have been
numerous reports describing the epidemiological and
clinical characteristics of H1N1 infections. However, stu-
dies focusing on the effects of respiratory pathogen
coinfection on clinical and laboratory parameters in the
H1N1 infected patients are scarce. Clinicians may
assume that a single virus type is involved, as laboratory
detection involves PCR specifically targeting H1N1.
However, bacterial coinfection had been shown to con-
tribute to morbidity and mortality in previous influenza
pandemics [4]. Therefore, this study aims to explore the
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any medium, provided the original work is properly cited.clinical and laboratory characteristics amongst patients
hospitalized with laboratory-confirmed pandemic influ-
enza A (H1N1) infection and the effects of bacterial
coinfection on these parameters.
Findings
Methodology
This retrospective study was conducted from September
2009 to May 2010 at Hospital Sultanah Aminah Johor
Bahru (HSAJB). HSAJB is a 989-bedded tertiary referral
centre and the government designated hospital for
H1N1 testing in Johor State, Malaysia. As the main
G e n e r a lH o s p i t a lo fJ o h o r ,i t s ’ patient population is
reflective of the larger community in Malaysia. During
our study period, which coincided with the peak of
H1N1 pandemic activity, all patients regardless of
whether they were hospitalized or not, who presented
with an influenza-like illness (ILI) were tested for H1N1.
Consecutive hospitalized patients with laboratory-con-
firmed H1N1 infections were identified from microbiol-
ogy laboratory records. Laboratory diagnosis of H1N1
was made using the Centers for Disease Control and
Prevention (CDC) real-time reverse transcriptase poly-
merase chain reaction (RT-PCR) protocol [5]. Relevant
clinical data was retrieved from patients’ medical
records. The presence of bacterial coinfection from
respiratory specimens (sputum, tracheal/nasopharyngeal
aspirate, bronchoalveolar lavage) or sterile site samples
(blood or pleural fluid) taken within 48 hours of admis-
sion was recorded. Mycoplasma pneumoniae infection
was diagnosed by serology using particle agglutination
test (Serodia- Myco II, Fujirebio Inc., Japan). A single
titer of ≥ 160 was considered as diagnostic cut-off titer,
based on population background study conducted in
Malaysia [6,7]. All samples confirmed H1N1 positive
were stored at -80°C for further analysis using multiplex
PCR (Seeplex RV Detection, USA) which detects adeno-
virus, influenza virus A and B, respiratory syncytial
virus, parainfluenza types 1, 2 and 3 and human metap-
neumovirus. Hematological, liver and renal function
parameters on admission were recorded.
Data was analyzed using SPSS version 17.0.1; compar-
ing patients with and without bacterial coinfection with
a P-value < 0.05 (two-tailed) taken as the level of signifi-
cance. Variables associated with bacterial coinfection in
the univariate analysis were then entered into multivari-
ate logistic regression analysis.
Results
After excluding 7 patients (5 incomplete data and 2 for
presence of nosocomial pneumonia), data of 50 patients
was available for analysis (Table 1). The patients age
ranged from 7 months to 82 years (median 20.3 years),
with 90% patients (45/50) < 50 years. Excluding 6
Table 1 Clinical and laboratory characteristics of
hospitalized patients with pandemic influenza A (H1N1)
2009 infections
Characteristics No of patients (N = 50) %
Male sex 25 50
Age < 50 45 90
Paediatric (≤ 15 years) 23 46
Cough 50 100
Fever 49 98
Dyspnoea 24 48
Rhinorrhoea 24 48
Sore throat* 16 36.4
Vomiting 12 24
Myalgia* 7 15.9
Headache* 7 15.9
Hypoxaemia 12 24
Tachypnoea 16 32
Pneumonia 25 50
Comorbidity** 24 48
Lung disease
¶ 11 22
Hypertension 5 10
Diabetes mellitus 5 10
Malignancy
Ψ 36
Autoimmune
¥ 24
Others
£ 61 2
Complications
® ** 13 26
Pregnant 6 12
Coinfection
Ω 17 34
Leukopenia
© 48
Lymphopaenia
© 31 62
Leukocytosis
© 12 24
Neutrophilia
© 13 26
ALF
§ 12 29.3
ARF
§ 4 9.5
ICU 9 18
Supplemental oxygen 22 44
Mechanical ventilation 6 12
Died 2 4
* Not assessed in children < 3 years (n = 44)
** A patient may have more than one comorbidity or complications
¶ Includes asthma (n- = 9), Chronic obstructive airway disease (n = 1) and
bronchiectasis (n = 1)
Ψ Includes chronic myeloid leukemia (n = 1), acute myeloid leukemia (n = 1),
meningioma of brain (n = 1)
¥ Includes autoimmune haemolytic anaemia (n = 1), idiopathic
thrombocytopenia purpura (n = 1)
£Includes cardiovascular disease (n = 2), immunosuppressives (n = 2),
hypothyroidism (n = 1), stroke (n = 1)
® Includes liver impairment (n = 12), renal impairment (n = 4) septic shock (n
= 2) and ARDS (n = 2).
Ω Includes bacterial (n = 14), viral (n = 3). The sites for isolation of 9 non-
Mycoplasma bacteria: (blood = 2, sputum = 3, nasopharyngeal aspirate = 3,
bronchoalveolar lavage = 2)
© Established values in our laboratory, Adults: leukocytes 4-11 × 10
9/L;
neutrophils 2-7.5 × 10
9/L; lymphocyte 1.5-4 × 10
9/L; Paediatrics: age-dependent
ALF: abnormal liver function (n = 41) (raised alanine aminotransferase/
aspartate aminotransferase or both)
ARF: abnormal renal function (n = 42) (raised creatinine)
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ing comorbidity; lung disease being the commonest. The
mean duration of symptoms before hospitalization was
4.4 ± 3.08 days (range 1-14 days). Cough (100%) and
fever (98%) were the most common symptoms on
admission. Twelve patients (24%) had oxygen saturation
< 95% at presentation. Pneumonia was diagnosed in 25
patients (50%) based on clinical and radiological
findings.
All patients received oseltamivir after admission.
Twenty-two patients (44%) required oxygen supplemen-
tation. Nine cases (18%) were treated at the intensive
care unit (ICU); 6 requiring mechanical ventilation.
Thirteen patients (26%) developed complications (single
or combination); liver impairment (n = 12), renal
impairment (n = 4) septic shock (n = 2) and acute
respiratory distress syndrome (ARDS) (n = 2). Two (4%)
patients died, resulting from septicaemic shock and
severe pneumonia respectively.
Impact of Bacterial Coinfection
Forty-five patients (90%) had lower respiratory tract spe-
cimens sent for bacterial cultures. The 5 patients with-
out these specimens were children who had difficulty in
producing respiratory secretions, however, they appeared
generally well with no evidence of pneumonia. Blood
cultures were performed in 23 patients (46%) and Myco-
plasma pneumoniae serology in 27 patients (54%). Of
the 50 H1N1 patients, 17 (34%) were coinfected with a
second respiratory pathogen; 14 (28%) bacterial and
only 3 (6%) viral. Mycoplasma pneumoniae (n = 5) was
the commonest bacterial coinfection followed by Staphy-
lococcus aureus (n = 3), Klebsiella pneumoniae (n = 2),
Streptococcus pneumoniae (n = 2), Moraxella catarrhalis
(n = 1), Pseudomonas aeruginosa (n = 1), Streptococcus
pyogenes (n = 1) and Streptococcus agalactiae (n = 1).
Two patients had dual infection; M.pneumoniae/S.aga-
lactiae and S.pneumoniae/M.catarrhalis respectively.
The sites for isolation of 9 non-Mycoplasma bacteria
were blood (2), sputum (3), nasopharyngeal aspirate (3)
and bronchoalveolar lavage (2). The 3 virus detected
were parainfluenza; these 3 patients presented with
influenza-like illness with no deterioration of clinical
findings.
A comparison between H1N1 patients with and with-
out bacterial coinfection is shown in Table 2. Although
90% of patients were < 50 years old, bacterial coinfec-
tion was more frequent in patients > 50 years (p =
0.02). The presence of underlying comorbidity provided
a suitable niche for bacterial coinfection (p = 0.04).
Although ICU admissions, mechanical ventilation, renal
impairment, mortality and pneumonia were notably
higher in patients with bacterial coinfection, they were
not statistically significant. Other factors associated with
bacterial coinfection in the univariate analysis were
development of complications (p = 0.004), liver impair-
ment (p = 0.02) and supplemental oxygen requirement
(p = 0.02). Out of the 50 patients, 12 (24%) had leukocy-
tosis and 13 (26%) neutrophilia. Bacterial coinfected
patients demonstrated higher rates of leukocytosis (p =
0.02) and neutrophilia (p = 0.004). On the other hand,
lymphopenia (n = 31) was notably higher in single viral
H1N1 infection. Multivariate analysis revealed that age
> 50 (OR 12.577; 95% CI 1-165.24; p = 0.05)) and devel-
opment of complications (OR 9.01; 95% CI 1.70-47.67; p
= 0.01) were predictive of bacterial coinfection.
Forty-one patients (82%) received antibiotics, either as
empiric or definitive therapy upon admission and 16%
prior to admission All patients with bacterial coinfection
were treated with antibiotics; significantly higher rates
compared to patients without bacterial coinfection (p =
0.05).
Discussion
The bacterial coinfection rate of 28% amongst our
H1N1 hospitalized patients was higher compared to
other studies [8,9]. A large laboratory-based study in the
United States demonstrated comparable bacterial coin-
fection rates to our study with similarly very low fre-
quency of viral copathogen detection [10]. Whilst our
finding concurred with several studies [1,8,9,11,12] that
showed H1N1 infections having a predilection for
younger patients, patients > 50 years had higher risk of
bacterial coinfection in our study.
Although concurrent bacterial infection was shown to
have a major influence on mortality in previous influenza
pandemics [4], its’ role in the current H1N1 pandemic is
still evolving. Recent postmortem studies amongst fatal
H1N1 cases established a link between bacterial lung
infections and increased deaths [13]. Whilst an earlier
study showed bacterial coinfection not to be a major con-
tributor to severe disease [12], a more recent study
demonstrated otherwise [8]. In our study, patients with
bacterial coinfection were found to have higher risk of
developing complications. The presence of underlying
comorbidity, liver impairment and supplemental oxygen
requirement were significantly higher in bacterial coin-
fected patients in univariate analysis, although these fac-
tors were not predictive in multivariate analysis.
Unlike S.pneumoniae, S.aureus and S.pyogenes which
are repeatedly reported as coinfecting agents [4,8,10,13],
the high rates of M.pneumoniae coinfection was unique
to our study. Although hematological parameters have
been mentioned in few other studies [8,9,12], to our
best knowledge this is the first study that specifically
explored the impact of bacterial coinfection on these
parameters. CDC recognizes the importance of early
empirical antibiotics in H1N1 infected patients who
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study showed that leukocytosis and neutrophilia were
notably higher in bacterial coinfected patients. This find-
ing could alert physicians about the possibility of bacter-
ial coinfection, as clinical diagnosis may be insufficient
and bacterial cultures take time. Eighty-two percent of
our patients received empiric or definitive antibiotics at
some point during admission which was comparable to
high rates in a China study [9].
The limitation of our study includes its’ retrospective
design and a small sample size which was unavoidable,
as we were limited by the actual number of cases during
the study period and because it was a single centre
study. As such, our study was inadequately powered to
examine the influence of certain characteristics. Naso-
pharyngeal aspirates may have questionable pathogenic
role, however the 3 patients with positive NPA were
treated with appropriate antibiotics as they were felt to
be clinically relevant. Mycoplasma serology was not per-
formed in all patients and the request was based upon
physicians’ discretion, this may have underestimated the
actual number of cases. The preadmission antibiotic
therapy could underestimate the bacterial coinfection
rates. Despite these limitations, we identified bacteria
coinfection in 28% of our patients.
In conclusion, our study suggests that bacterial coin-
fection is not uncommon in H1N1 infected patients and
laboratory investigations should go beyond establishing
a viral cause alone. Bacterial coinfection was more fre-
quently seen in the older age group and was associated
with higher rates of complications. As adjunct to clinical
findings, clinicians need to have a high index of suspi-
cion if neutrophilia was identified on admission as it
may denote bacterial coinfection. A larger scale study
will be useful to further confirm our findings.
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Table 2 Comparison between hospitalized pandemic influenza A (H1N1) patients with or without bacterial coinfection
Variable All patients
n(%)/median(± IQR)
N=5 0
Bacterial coinfection
n(%)/median(± IQR)
P OR 95% C1
Yes (n = 14) No (n = 36)
Male
b 25(50) 7(50.0) 18(50.0) 1.00 1.00 0.29-3.44
Age > 50
a 5(10) 4(28.6) 1(2.8) 0.02 14.00 1.40-139.81
Paediatric
b 23(46) 7(50.0) 16(44.4) 0.72 1.25 0.36-4.31
Dyspnoea
b 24(48) 7(50.0) 17(47.2) 0.86 1.12 0.33-3.84
Hypoxaemia
a 12(24) 5(35.7) 7(19.4) 0.28 2.30 0.59-9.06
Comorbidity
b 24(48) 10(71.4) 14(38.9) 0.04 3.93 1.03-15.00
Diabetes mellitus
a 5(10) 3(21.4) 2(5.6) 0.13 4.64 0.68-31.44
Hypertension
a 5(10) 3(21.4) 2(5.6) 0.13 4.64 0.68-31.44
Lung disease
a 11(22) 4(28.6) 7(19.4) 0.48 1.66 0.40-6.88
Pregnancy
a 6(12) 1(7.1) 5(13.9) 0.66 0.48 0.05-4.50
Leukopenia
a 4(8) 1(7.1) 3(8.3) 1 0.85 0.08-8.89
Lymphopaenia
b 31(62) 6(42.9) 25(69.4) 0.08 0.33 0.09-1.18
Leukocytosis
a 12(24) 7(50.0) 5(13.9) 0.02 6.20 1.51-25.41
Neutrophilia
a 13(26) 8(57.1) 5(13.9) 0.004 8.27 2.00-34.16
Liver impairment
a 12(29.3) 7(53.8) 5(17.9) 0.02 6.72 1.50-30.07
Renal impairment
a 4(9.5) 3(25.0) 1(3.3) 0.06 9.67 O.89-104.82
Supplemental oxygen
b 22(44) 10(71.4) 12(33.3) 0.02 5.00 1.30-19.30
Mechanical ventilation
a 6(12) 3(21.4) 3(8.3) 0.33 3.00 0.53-17.09
ICU stay
a 9(18) 4(28.6) 5(13.9) 0.25 2.48 0.56-11.07
Pneumonia
b 25(50) 9(64.3) 16(44.4) 0.21 0.44 0.12-1.60
Complications
a 13(26) 8(57.1) 5(13.9) 0.004 8.27 2.00-34.16
Died
a 2(4) 2(14.3) 0(0) 0.07 0.25 0.15-0.41
Antibiotics on admission
a 41(82) 14(100) 27(75.0) 0.05 1.52 1.22-1.89
Antibiotics pre-admission
a 8(16) 3(21.4) 5(13.9) 0.67 1.70 0.35-8.28
Duration of hospitalization
c 5(3) 5(3.5) 5(3.25) 0.25 Non applicable
a Fisher’s exact test;
bChi-squared test;
cNon-parametric Mann-Whitney test.
a and
b expressed as number (%);
c expressed as median (± IQR)
N = 50 for all patients except liver impairment n = 41 and renal impairment n = 42
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